We are live on ! Find out more
JSAM

J. Safra Asset Management Portfolio holdings

AUM $2.17B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.74%
1 Year Est. Return
+29.66%
3 Year Est. Return
+84.26%
5 Year Est. Return
+107.54%
10 Year Est. Return
AUM
$1.65B
AUM Growth
+$210M
Cap. Flow
+$87M
Cap. Flow %
5.28%
Top 10 Hldgs %
68.85%
Holding
505
New
138
Increased
161
Reduced
108
Closed
36

Sector Composition

Rank Sector Weight
1 Technology 3.5%
2 Communication Services 1.94%
3 Financials 1.1%
4 Consumer Discretionary 0.87%
5 Healthcare 0.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRNX icon
326
Crinetics Pharmaceuticals
CRNX
$8.95B
$4K ﹤0.01%
96
+4
+4% +$128
VRDN icon
327
Viridian Therapeutics
VRDN
$2.6B
$3.88K ﹤0.01%
180
CARR icon
328
Carrier Global
CARR
$52.4B
$3.88K ﹤0.01%
+65
New +$4.42K
COGT icon
329
Cogent Biosciences
COGT
$6.61B
$3.82K ﹤0.01%
266
VCYT icon
330
Veracyte
VCYT
$3.73B
$3.81K ﹤0.01%
111
EVRG icon
331
Evergy
EVRG
$18.9B
$3.8K ﹤0.01%
+50
New +$3.56K
FOXA icon
332
Fox Class A
FOXA
$26.1B
$3.78K ﹤0.01%
+60
New +$3.47K
VRT icon
333
Vertiv
VRT
$108B
$3.77K ﹤0.01%
+25
New +$3.33K
AIZ icon
334
Assurant
AIZ
$13.9B
$3.68K ﹤0.01%
17
-80
-82% -$16.2K
D icon
335
Dominion Energy
D
$59.9B
$3.67K ﹤0.01%
+60
New +$3.57K
CROX icon
336
Crocs
CROX
$6.31B
$3.51K ﹤0.01%
42
-203
-83% -$18.5K
XENE icon
337
Xenon Pharmaceuticals
XENE
$6.11B
$3.49K ﹤0.01%
87
RZLT icon
338
Rezolute
RZLT
$445M
$3.41K ﹤0.01%
+363
New +$2.42K
ONC
339
BeOne Medicines Ltd
ONC
$40.6B
$3.41K ﹤0.01%
10
COIN icon
340
Coinbase
COIN
$39.2B
$3.38K ﹤0.01%
+10
New +$3.39K
REVG
341
DELISTED
REV Group
REVG
$3.34K ﹤0.01%
59
-284
-83% -$15.1K
ACLX
342
DELISTED
Arcellx
ACLX
$3.28K ﹤0.01%
40
EQT icon
343
EQT Corp
EQT
$34B
$3.27K ﹤0.01%
+60
New +$3.17K
HAFC icon
344
Hanmi Financial
HAFC
$948M
$3.21K ﹤0.01%
130
-629
-83% -$15.5K
ELAN icon
345
Elanco Animal Health
ELAN
$11.4B
$3.2K ﹤0.01%
159
-777
-83% -$13K
KMI icon
346
Kinder Morgan
KMI
$70.1B
$3.2K ﹤0.01%
+113
New +$3.09K
STOK icon
347
Stoke Therapeutics
STOK
$2.13B
$3.15K ﹤0.01%
+134
New +$2.3K
SBAC icon
348
SBA Communications
SBAC
$19.3B
$3.09K ﹤0.01%
+16
New +$3.46K
INCY icon
349
Incyte
INCY
$24.5B
$2.97K ﹤0.01%
+35
New +$2.77K
SF
350
Stifel
SF
$12.7B
$2.95K ﹤0.01%
39
-150
-79% -$11.2K

Similar funds

J. Safra Asset Management's Q3 2025 Portfolio in Review

As of Q3 2025, J. Safra Asset Management held 505 positions worth $1.65B, up 15% from $1.44B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

J. Safra Asset Management deployed $87M of net new capital in Q3 2025, opening 138 new positions and adding to 161 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 1,011,916 shares worth $72.2M.

By sector, the portfolio is most concentrated in Technology at 3.5% of assets, up from 2.8% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Invesco S&P 500 Equal Weight ETF, an estimated $43.4M trimmed.

  • J. Safra Asset Management's largest Q3 2025 buy was Vanguard FTSE All-World ex-US ETF: 1,011,916 shares worth $72.2M.
  • J. Safra Asset Management added most to State Street Technology Select Sector SPDR ETF in Q3 2025, an estimated $9.43M increase.
  • J. Safra Asset Management's biggest Q3 2025 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $43.4M.
  • J. Safra Asset Management fully exited iShares Ultra Short Duration Bond Active ETF in Q3 2025, selling an estimated $895K.
  • J. Safra Asset Management's ten largest holdings make up 69% of its $1.65B portfolio in Q3 2025.
  • J. Safra Asset Management opened 138 new positions and closed 36 in Q3 2025.
  • J. Safra Asset Management's portfolio value rose 15% quarter-over-quarter to $1.65B.

Based on J. Safra Asset Management's 13F filing for Q3 2025, filed 29 Oct 2025.